Analytics

Providers are responsible for navigating variable coverage schemes while caring for patients, says Jay Rughani, investment partner at Andreessen Horowitz. AI and LLMs advancements can help fix this trajectory and reduce administrative burnout.  

Brigid Bondoc, partner and life sciences attorney at Morrison Foerster, discusses government priorities pertaining to federal regulation of AI, where complications may arise, and concerns she has heard related to policy decisions.  

Cybersecurity officers are up against well-equipped adversaries like crime syndicates, says Richard Staynings, chief security strategist at Cylera. AI can help automate and improve cybersecurity tools if adequately implemented.  

Thomas Hallisey, HANYS digital health strategy lead, discusses appropriate regulations on digital health at the state and federal levels and the need for continuous management as technology moves from automating healthcare to augmenting it.  

AI is a tool to help people everywhere realize their health potential, said HIMSS Chief Scientific Research Officer Anne Snowden. If there was a time for learning, sharing and building a community of AI decision-making tools, it is now.  

As host of HIMSS AI in Healthcare Forum, Robert Havasy, senior director of the Personal Connected Health Alliance at HIMSS, discusses the cautious optimism and warnings he heard from speakers and attendees about AI technology and its progress.  

The American Medical Association uses “augmented intelligence,” not “artificial intelligence,” as the tech is meant to support, not replace, people, said Dr. Jesse Ehrenfeld, president of the AMA. Still, new regulatory paradigms are needed.

Updesh Dosanjh, practice leader of technology solutions for lQVIA, discusses ensuring fairness while using AI in clinical trials, the value of digital twins and the necessity of building and consistently adapting frameworks around AI use.  

Peter Shen, head of the digital and automation business at Siemens Healthineers, discusses the value of adopting a Hippocratic Oath and ethical standards for AI use in healthcare to ensure the safe creation and training of algorithms.

Davidi Vortman, CEO of UltraSight, discusses the company's AI-driven cardiac-imaging technology that helps providers quickly and efficiently triage patients and the ways the FDA-cleared system is used in the U.S. and globally.